Skip to main content
Clinical Trials/NCT05039021
NCT05039021
Completed
Not Applicable

A Prospective, Single-Arm Multi-Center Study of the HARMONIC® 1100 Shears and Generator G11 in Pediatric Surgical Procedures (General) and Adult Surgical Procedures (General, Gynecological, Urological, and Thoracic)

Ethicon Endo-Surgery7 sites in 3 countries265 target enrollmentJuly 29, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pediatric Procedures
Sponsor
Ethicon Endo-Surgery
Enrollment
265
Locations
7
Primary Endpoint
Number of Vessels Transected With Less Than or Equal to (<=) Grade 3 Hemostasis Based on Hemostasis Grading Scale
Status
Completed
Last Updated
last year

Overview

Brief Summary

This prospective, single-arm, multi-center study will collect clinical data in a post-market setting for the pediatric population (general surgical procedures) and adult population (general, gynecological, urological, and thoracic surgical procedures). Investigators will perform each procedure using the device in compliance with their standard surgical approach and the HARMONIC 1100 Shears and Generator G11 instructions for use.

Registry
clinicaltrials.gov
Start Date
July 29, 2021
End Date
March 12, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Ethicon Endo-Surgery
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Pediatric population:
  • Non-emergent procedure (general) where at least one vessel is planned to be transected by the HARMONIC 1100 Shears per the IFU;
  • Less than 18 years of age at the time of procedure; and
  • The subject's parent/legal guardian must be willing to give permission for the subject to participate in the study and provide written informed consent for the subject. In addition, assent must be obtained from pediatric subjects who possess the intellectual and emotional ability to comprehend the concepts involved in the study. If the pediatric subject is not able to provide assent (due to age, maturity and/or inability to intellectually and/or emotionally comprehend the study), the parent/legal guardian's written informed consent for the subject will be acceptable for the subject to be included in the study.
  • Adult population:
  • Elective procedure (general, gynecological, urological, or thoracic) where at least one vessel is planned to be transected by the HARMONIC 1100 Shears per the IFU;
  • Willingness to give consent and comply with all study-related evaluations and visit schedule; and
  • At least 18 years of age.

Exclusion Criteria

  • Preoperative
  • Physical or psychological condition which would impair study participation;
  • Female subjects, of childbearing age, who are pregnant; or
  • Enrollment in a concurrent interventional clinical study that could impact the study endpoints.
  • Intraoperative
  • The HARMONIC 1100 Shears were not attempted to be used for at least one single vessel transection during the surgical procedure.

Outcomes

Primary Outcomes

Number of Vessels Transected With Less Than or Equal to (<=) Grade 3 Hemostasis Based on Hemostasis Grading Scale

Time Frame: On the day of transection (Day 0)

Number of vessels transected with \<= Grade 3 hemostasis based on hemostasis grading scale were reported. A 4-point grading scale was used to assess hemostasis in blood vessels. Grade 1: no bleeding at transection site; Grade 2: minor bleeding at transection site, no intervention needed; Grade 3: minor bleeding at transection site, mild intervention needed, use of compression, monopolar device and/or touch-ups with HARMONIC 1100 Shears; or Grade 4: significant bleeding (example, pulsatile blood flow, venous pooling) requiring intervention such as extensive coagulation or use of additional hemostatic measures (example, hemoclips, staples, sutures, fibrin sealants, other advanced energy products).

Number of Participants With Device-related Adverse Events (AEs)

Time Frame: From Day 0 up to post-procedure follow up visit (up to 28 days)

Number of participants with device-related AEs were reported. Device-related AEs were those AEs identified as having a relationship of possibly, probably, or causally with the study device. Possible refers to the relationship with the use of the device is weak but cannot be ruled out completely; Probable refers to the relationship with the use of the device seems relevant and/or the event cannot reasonably be explained by another cause, but additional information may be obtained; Causal relationship refers to the event is associated with the device or with procedures beyond reasonable doubt.

Secondary Outcomes

  • Number of Vessels Transections With Diameter >5 to 7 mm With Less Than or Equal to (<=) Grade 3 Hemostasis Based on Hemostasis Grading Scale(On the day of transection (Day 0))
  • Number of Participants Using HARMONIC 1100 Shears For Sealing and Transection of Lymphatic Vessels as Assessed by Surgeon Satisfaction Scale Score(On the day of transection (Day 0))
  • Number of Vessels Transected With Hemostasis (Grade 1 to 4) Based on Hemostasis Grading Scale(On the day of transection (Day 0))
  • Number of Grade 4 Vessel Transections Requiring Hemostasis Measures(On the day of transection (Day 0))

Study Sites (7)

Loading locations...

Similar Trials